Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce
Joshua P. Vogel, Britta Tendal, Michelle Giles, Clare Whitehead, Wendy Burton, Samantha Chakraborty, Saskia Cheyne, Teena Downton, David Fraile Navarro, Glenda Gleeson, Adrienne Gordon, Jenny Hunt, Jackie Kitschke, Steve McDonald, Nolan McDonnell, Philippa Middleton, Tanya Millard, Melissa Murano, Jeremy Oats, Rhiannon Tate, Heath White, Julian Elliott, Vijay Roach, Caroline Homer
Abstract
To date, 18 living recommendations for the clinical care of pregnant and postpartum women with COVID-19 have been issued by the National COVID-19 Clinical Evidence Taskforce. This includes recommendations on mode of birth, delayed umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, antenatal corticosteroids, angiotensin-converting enzyme inhibitors, disease-modifying treatments (including dexamethasone, remdesivir and hydroxychloroquine), venous thromboembolism prophylaxis and advanced respiratory support interventions (prone positioning and extracorporeal membrane oxygenation). Through continuous evidence surveillance, these living recommendations are updated in near real-time to ensure clinicians in Australia have reliable, evidence-based guidelines for clinical decision-making. Please visit https://covid19evidence.net.au/ for the latest recommendation updates.